Literature DB >> 2658105

Liver transplantation for primary biliary cirrhosis.

A G Tzakis1, C Carcassonne, S Todo, L Makowka, T E Starzl.   

Abstract

Liver transplantation is an effective treatment for PBC. The Pittsburgh experience is reported, with 1- and 5-year survival of 75.62% and 70.71%, respectively. Recurrence of PBC, when it occurs, has not been of clinical significance. Transplantation markedly improves chances for survival, an advantage that is demonstrable in all of the risk groups. Rehabilitation is achieved after transplantation in approximately 90% of the patients. Some clinical variables are associated with a poorer outcome and indicate the need for earlier treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2658105      PMCID: PMC2965607          DOI: 10.1055/s-2008-1040506

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  23 in total

1.  Hepatic Retransplantation.

Authors:  B W Shaw; R D Gordon; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

2.  Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; C O Esquivel; A G Tzakis; L Makowka; J W Marsh; B Koneru; A Stieber
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

3.  Liver transplantation in older patients.

Authors:  T E Starzl; S Todo; R Gordon; L Makowa; A Tzakis; S Iwatsuki; W Marsh; C Esquivel; D Van Thiel
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

4.  Veno-venous bypass without systemic anticoagulation for transplantation of the human liver.

Authors:  B P Griffith; B W Shaw; R L Hardesty; S Iwatsuki; H T Bahnson; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1985-03

5.  Alternative methods of arterialization of the hepatic graft.

Authors:  B W Shaw; S Iwatsuki; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1984-11

6.  Liver transplantation, 1980, with particular reference to cyclosporin-A.

Authors:  T E Starzl; S Iwatsuki; G Klintmalm; G P Schröter; R Weil; L J Koep; K A Porter
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation.

Authors:  M Adler; J S Gavaler; R Duquesnoy; J J Fung; G Svanas; T E Starzl; D H van Thiel
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

8.  Extended preservation of human liver grafts with UW solution.

Authors:  S Todo; J Nery; K Yanaga; L Podesta; R D Gordon; T E Starzl
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272

9.  Recurrence of primary biliary cirrhosis after liver transplantation.

Authors:  J Neuberger; B Portmann; B R Macdougall; R Y Calne; R Williams
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

10.  The use of cyclosporin A and prednisone in cadaver kidney transplantation.

Authors:  T E Starzl; R Weil; S Iwatsuki; G Klintmalm; G P Schröter; L J Koep; Y Iwaki; P I Terasaki; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1980-07
View more
  2 in total

1.  Referral of patients with primary biliary cirrhosis for liver transplantation.

Authors:  J M Neuberger; B K Gunson; J A Buckels; E Elias; P McMaster
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  Dermatological Disorders following Liver Transplantation: An Update.

Authors:  Dipesh Kumar Yadav; Xue Li Bai; Tingbo Liang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.